Observational studyAnnals of hematology2024

Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib.

Lucía Pérez-Lamas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.